Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GDX012 |
Trade Name | |
Synonyms | GDX 012|GDX-012 |
Drug Descriptions |
GDX012 is an allogeneic cell therapy comprising gamma delta T-lymphocytes, which potentially induce cytotoxicity in tumor cells (Cancer Res (2022) 82 (12_Supplement): CT525). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C182633 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
GDX012 | GDX012 | 0 | 1 |